Behavioral despair associated with a mouse model of Crohn's disease: Role of nitric oxide pathway

Crohn's disease (CD) is associated with increased psychiatric co-morbidities. Nitric oxide (NO) is implicated in inflammation and tissue injury in CD, and it may also play a central role in pathogenesis of the accompanying behavioral despair. This study investigated the role of the NO pathway i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Progress in neuro-psychopharmacology & biological psychiatry 2016-01, Vol.64, p.131-141
Hauptverfasser: Heydarpour, Pouria, Rahimian, Reza, Fakhfouri, Gohar, Khoshkish, Shayan, Fakhraei, Nahid, Salehi-Sadaghiani, Mohammad, Wang, Hongxing, Abbasi, Ata, Dehpour, Ahmad Reza, Ghia, Jean-Eric
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 141
container_issue
container_start_page 131
container_title Progress in neuro-psychopharmacology & biological psychiatry
container_volume 64
creator Heydarpour, Pouria
Rahimian, Reza
Fakhfouri, Gohar
Khoshkish, Shayan
Fakhraei, Nahid
Salehi-Sadaghiani, Mohammad
Wang, Hongxing
Abbasi, Ata
Dehpour, Ahmad Reza
Ghia, Jean-Eric
description Crohn's disease (CD) is associated with increased psychiatric co-morbidities. Nitric oxide (NO) is implicated in inflammation and tissue injury in CD, and it may also play a central role in pathogenesis of the accompanying behavioral despair. This study investigated the role of the NO pathway in behavioral despair associated with a mouse model of CD. Colitis was induced by intrarectal (i.r.) injection of 2,4,6-trinitrobenzenesulfonic acid (10mg TNBS in 50% ethanol). Forced swimming test (FST), pharmacological studies and tissues collection were performed 72h following TNBS administration. To address a possible inflammatory origin for the behavioral despair following colitis induction, tumor necrosis factor-alpha (TNF-α) level was measured in both the hippocampal and colonic tissue samples. In parallel, hippocampal inducible nitric oxide synthase (iNOS) and nitrite level were evaluated. Pharmacological studies targeting the NO pathway were performed 30–60min before behavioral test. Colitis was confirmed by increased colonic TNF-α level and microscopic score. Colitic mice demonstrated a significantly higher immobility time in the FST associated to a significant increase of hippocampal TNF-α, iNOS expression and nitrite content. Acute NOS inhibition using either Nω-nitro-l-arginine methyl ester (a non-specific NOS inhibitor) or aminoguanidine hydrochloride (a specific iNOS inhibitor) decreased the immobility time in colitic groups. Moreover, acute treatment with both NOS inhibitors decreased the TNF-α level and nitrite content in the hippocampal samples. This study suggests that the NO pathway may be involved in the behavioral effects in the mouse TNBS model of CD. These findings endow new insights into the gut-brain communication during the development of colonic inflammation, which may ultimately lead to improved therapeutic strategies to combat behavior changes associated with gastrointestinal disorders. [Display omitted] •Colitis in mice is accompanied by an increase in the severity of behavioral despair.•Hippocampal iNOS, TNF-alpha and nitrite level are up-regulated.•NOS & iNOS inhibitors attenuated the behavioral despair and central markers studied.
doi_str_mv 10.1016/j.pnpbp.2015.08.004
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1710653006</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0278584615300245</els_id><sourcerecordid>1710653006</sourcerecordid><originalsourceid>FETCH-LOGICAL-c309t-be94c36136e8975bab157d9a7375321224e2e90801e19d8254ae910673de9b683</originalsourceid><addsrcrecordid>eNp9kMFOGzEQQK0KVFLaL6hU-QaXLGN712tX6gGi0iIhIaH2bHntieJos97amwB_j9MARy7jkeaNZ-YR8pVBxYDJi3U1DmM3VhxYU4GqAOoPZMZUq-Y1Z_KIzICXvFG1PCGfcl4DABMgPpITLrlUWvAZsVe4srsQk-2pxzzakKjNObpgJ_T0IUwraukmbjOW6LGncUkXKa6Gs0x9yGgzfqf3scd9YQhTCo7Gx-CRjnZaPdinz-R4afuMX17eU_L3-uefxe_57d2vm8Xl7dwJ0NO8Q107IZmQqHTbdLZjTeu1bUXbCM44r5GjBgUMmfaKN7VFzUC2wqPupBKn5Pzw75jivy3myWxCdtj3dsCyvmFtoRsBIAsqDqhLMeeESzOmsLHpyTAwe7dmbf67NXu3BpQpbkvXt5cB226D_q3nVWYBfhwALGfuAiaTXcDBoQ8J3WR8DO8OeAZjBIq9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1710653006</pqid></control><display><type>article</type><title>Behavioral despair associated with a mouse model of Crohn's disease: Role of nitric oxide pathway</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Heydarpour, Pouria ; Rahimian, Reza ; Fakhfouri, Gohar ; Khoshkish, Shayan ; Fakhraei, Nahid ; Salehi-Sadaghiani, Mohammad ; Wang, Hongxing ; Abbasi, Ata ; Dehpour, Ahmad Reza ; Ghia, Jean-Eric</creator><creatorcontrib>Heydarpour, Pouria ; Rahimian, Reza ; Fakhfouri, Gohar ; Khoshkish, Shayan ; Fakhraei, Nahid ; Salehi-Sadaghiani, Mohammad ; Wang, Hongxing ; Abbasi, Ata ; Dehpour, Ahmad Reza ; Ghia, Jean-Eric</creatorcontrib><description>Crohn's disease (CD) is associated with increased psychiatric co-morbidities. Nitric oxide (NO) is implicated in inflammation and tissue injury in CD, and it may also play a central role in pathogenesis of the accompanying behavioral despair. This study investigated the role of the NO pathway in behavioral despair associated with a mouse model of CD. Colitis was induced by intrarectal (i.r.) injection of 2,4,6-trinitrobenzenesulfonic acid (10mg TNBS in 50% ethanol). Forced swimming test (FST), pharmacological studies and tissues collection were performed 72h following TNBS administration. To address a possible inflammatory origin for the behavioral despair following colitis induction, tumor necrosis factor-alpha (TNF-α) level was measured in both the hippocampal and colonic tissue samples. In parallel, hippocampal inducible nitric oxide synthase (iNOS) and nitrite level were evaluated. Pharmacological studies targeting the NO pathway were performed 30–60min before behavioral test. Colitis was confirmed by increased colonic TNF-α level and microscopic score. Colitic mice demonstrated a significantly higher immobility time in the FST associated to a significant increase of hippocampal TNF-α, iNOS expression and nitrite content. Acute NOS inhibition using either Nω-nitro-l-arginine methyl ester (a non-specific NOS inhibitor) or aminoguanidine hydrochloride (a specific iNOS inhibitor) decreased the immobility time in colitic groups. Moreover, acute treatment with both NOS inhibitors decreased the TNF-α level and nitrite content in the hippocampal samples. This study suggests that the NO pathway may be involved in the behavioral effects in the mouse TNBS model of CD. These findings endow new insights into the gut-brain communication during the development of colonic inflammation, which may ultimately lead to improved therapeutic strategies to combat behavior changes associated with gastrointestinal disorders. [Display omitted] •Colitis in mice is accompanied by an increase in the severity of behavioral despair.•Hippocampal iNOS, TNF-alpha and nitrite level are up-regulated.•NOS &amp; iNOS inhibitors attenuated the behavioral despair and central markers studied.</description><identifier>ISSN: 0278-5846</identifier><identifier>EISSN: 1878-4216</identifier><identifier>DOI: 10.1016/j.pnpbp.2015.08.004</identifier><identifier>PMID: 26268932</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Animals ; Antidepressive Agents - pharmacology ; Behavioral despair ; Colitis - pathology ; Colitis - physiopathology ; Colitis - psychology ; Colon - drug effects ; Colon - metabolism ; Colon - pathology ; Crohn Disease - drug therapy ; Crohn Disease - pathology ; Crohn Disease - physiopathology ; Crohn Disease - psychology ; Depression - drug therapy ; Depression - pathology ; Depression - physiopathology ; Disease Models, Animal ; Enzyme Inhibitors - pharmacology ; Guanidines - pharmacology ; Hippocampus - drug effects ; Hippocampus - metabolism ; Hippocampus - pathology ; Inflammatory bowel disease ; Male ; Mice ; Motor Activity - drug effects ; Motor Activity - physiology ; NG-Nitroarginine Methyl Ester - pharmacology ; Nitric oxide ; Nitric Oxide - metabolism ; Nitric Oxide Synthase Type II - antagonists &amp; inhibitors ; Nitric Oxide Synthase Type II - metabolism ; Nitrites - metabolism ; Signal Transduction - drug effects ; TNF-α ; Trinitrobenzenesulfonic Acid ; Tumor Necrosis Factor-alpha - metabolism</subject><ispartof>Progress in neuro-psychopharmacology &amp; biological psychiatry, 2016-01, Vol.64, p.131-141</ispartof><rights>2015</rights><rights>Copyright © 2015. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c309t-be94c36136e8975bab157d9a7375321224e2e90801e19d8254ae910673de9b683</cites><orcidid>0000-0002-3018-9719</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.pnpbp.2015.08.004$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26268932$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Heydarpour, Pouria</creatorcontrib><creatorcontrib>Rahimian, Reza</creatorcontrib><creatorcontrib>Fakhfouri, Gohar</creatorcontrib><creatorcontrib>Khoshkish, Shayan</creatorcontrib><creatorcontrib>Fakhraei, Nahid</creatorcontrib><creatorcontrib>Salehi-Sadaghiani, Mohammad</creatorcontrib><creatorcontrib>Wang, Hongxing</creatorcontrib><creatorcontrib>Abbasi, Ata</creatorcontrib><creatorcontrib>Dehpour, Ahmad Reza</creatorcontrib><creatorcontrib>Ghia, Jean-Eric</creatorcontrib><title>Behavioral despair associated with a mouse model of Crohn's disease: Role of nitric oxide pathway</title><title>Progress in neuro-psychopharmacology &amp; biological psychiatry</title><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><description>Crohn's disease (CD) is associated with increased psychiatric co-morbidities. Nitric oxide (NO) is implicated in inflammation and tissue injury in CD, and it may also play a central role in pathogenesis of the accompanying behavioral despair. This study investigated the role of the NO pathway in behavioral despair associated with a mouse model of CD. Colitis was induced by intrarectal (i.r.) injection of 2,4,6-trinitrobenzenesulfonic acid (10mg TNBS in 50% ethanol). Forced swimming test (FST), pharmacological studies and tissues collection were performed 72h following TNBS administration. To address a possible inflammatory origin for the behavioral despair following colitis induction, tumor necrosis factor-alpha (TNF-α) level was measured in both the hippocampal and colonic tissue samples. In parallel, hippocampal inducible nitric oxide synthase (iNOS) and nitrite level were evaluated. Pharmacological studies targeting the NO pathway were performed 30–60min before behavioral test. Colitis was confirmed by increased colonic TNF-α level and microscopic score. Colitic mice demonstrated a significantly higher immobility time in the FST associated to a significant increase of hippocampal TNF-α, iNOS expression and nitrite content. Acute NOS inhibition using either Nω-nitro-l-arginine methyl ester (a non-specific NOS inhibitor) or aminoguanidine hydrochloride (a specific iNOS inhibitor) decreased the immobility time in colitic groups. Moreover, acute treatment with both NOS inhibitors decreased the TNF-α level and nitrite content in the hippocampal samples. This study suggests that the NO pathway may be involved in the behavioral effects in the mouse TNBS model of CD. These findings endow new insights into the gut-brain communication during the development of colonic inflammation, which may ultimately lead to improved therapeutic strategies to combat behavior changes associated with gastrointestinal disorders. [Display omitted] •Colitis in mice is accompanied by an increase in the severity of behavioral despair.•Hippocampal iNOS, TNF-alpha and nitrite level are up-regulated.•NOS &amp; iNOS inhibitors attenuated the behavioral despair and central markers studied.</description><subject>Animals</subject><subject>Antidepressive Agents - pharmacology</subject><subject>Behavioral despair</subject><subject>Colitis - pathology</subject><subject>Colitis - physiopathology</subject><subject>Colitis - psychology</subject><subject>Colon - drug effects</subject><subject>Colon - metabolism</subject><subject>Colon - pathology</subject><subject>Crohn Disease - drug therapy</subject><subject>Crohn Disease - pathology</subject><subject>Crohn Disease - physiopathology</subject><subject>Crohn Disease - psychology</subject><subject>Depression - drug therapy</subject><subject>Depression - pathology</subject><subject>Depression - physiopathology</subject><subject>Disease Models, Animal</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Guanidines - pharmacology</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - metabolism</subject><subject>Hippocampus - pathology</subject><subject>Inflammatory bowel disease</subject><subject>Male</subject><subject>Mice</subject><subject>Motor Activity - drug effects</subject><subject>Motor Activity - physiology</subject><subject>NG-Nitroarginine Methyl Ester - pharmacology</subject><subject>Nitric oxide</subject><subject>Nitric Oxide - metabolism</subject><subject>Nitric Oxide Synthase Type II - antagonists &amp; inhibitors</subject><subject>Nitric Oxide Synthase Type II - metabolism</subject><subject>Nitrites - metabolism</subject><subject>Signal Transduction - drug effects</subject><subject>TNF-α</subject><subject>Trinitrobenzenesulfonic Acid</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><issn>0278-5846</issn><issn>1878-4216</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFOGzEQQK0KVFLaL6hU-QaXLGN712tX6gGi0iIhIaH2bHntieJos97amwB_j9MARy7jkeaNZ-YR8pVBxYDJi3U1DmM3VhxYU4GqAOoPZMZUq-Y1Z_KIzICXvFG1PCGfcl4DABMgPpITLrlUWvAZsVe4srsQk-2pxzzakKjNObpgJ_T0IUwraukmbjOW6LGncUkXKa6Gs0x9yGgzfqf3scd9YQhTCo7Gx-CRjnZaPdinz-R4afuMX17eU_L3-uefxe_57d2vm8Xl7dwJ0NO8Q107IZmQqHTbdLZjTeu1bUXbCM44r5GjBgUMmfaKN7VFzUC2wqPupBKn5Pzw75jivy3myWxCdtj3dsCyvmFtoRsBIAsqDqhLMeeESzOmsLHpyTAwe7dmbf67NXu3BpQpbkvXt5cB226D_q3nVWYBfhwALGfuAiaTXcDBoQ8J3WR8DO8OeAZjBIq9</recordid><startdate>20160104</startdate><enddate>20160104</enddate><creator>Heydarpour, Pouria</creator><creator>Rahimian, Reza</creator><creator>Fakhfouri, Gohar</creator><creator>Khoshkish, Shayan</creator><creator>Fakhraei, Nahid</creator><creator>Salehi-Sadaghiani, Mohammad</creator><creator>Wang, Hongxing</creator><creator>Abbasi, Ata</creator><creator>Dehpour, Ahmad Reza</creator><creator>Ghia, Jean-Eric</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3018-9719</orcidid></search><sort><creationdate>20160104</creationdate><title>Behavioral despair associated with a mouse model of Crohn's disease: Role of nitric oxide pathway</title><author>Heydarpour, Pouria ; Rahimian, Reza ; Fakhfouri, Gohar ; Khoshkish, Shayan ; Fakhraei, Nahid ; Salehi-Sadaghiani, Mohammad ; Wang, Hongxing ; Abbasi, Ata ; Dehpour, Ahmad Reza ; Ghia, Jean-Eric</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c309t-be94c36136e8975bab157d9a7375321224e2e90801e19d8254ae910673de9b683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Antidepressive Agents - pharmacology</topic><topic>Behavioral despair</topic><topic>Colitis - pathology</topic><topic>Colitis - physiopathology</topic><topic>Colitis - psychology</topic><topic>Colon - drug effects</topic><topic>Colon - metabolism</topic><topic>Colon - pathology</topic><topic>Crohn Disease - drug therapy</topic><topic>Crohn Disease - pathology</topic><topic>Crohn Disease - physiopathology</topic><topic>Crohn Disease - psychology</topic><topic>Depression - drug therapy</topic><topic>Depression - pathology</topic><topic>Depression - physiopathology</topic><topic>Disease Models, Animal</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Guanidines - pharmacology</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - metabolism</topic><topic>Hippocampus - pathology</topic><topic>Inflammatory bowel disease</topic><topic>Male</topic><topic>Mice</topic><topic>Motor Activity - drug effects</topic><topic>Motor Activity - physiology</topic><topic>NG-Nitroarginine Methyl Ester - pharmacology</topic><topic>Nitric oxide</topic><topic>Nitric Oxide - metabolism</topic><topic>Nitric Oxide Synthase Type II - antagonists &amp; inhibitors</topic><topic>Nitric Oxide Synthase Type II - metabolism</topic><topic>Nitrites - metabolism</topic><topic>Signal Transduction - drug effects</topic><topic>TNF-α</topic><topic>Trinitrobenzenesulfonic Acid</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Heydarpour, Pouria</creatorcontrib><creatorcontrib>Rahimian, Reza</creatorcontrib><creatorcontrib>Fakhfouri, Gohar</creatorcontrib><creatorcontrib>Khoshkish, Shayan</creatorcontrib><creatorcontrib>Fakhraei, Nahid</creatorcontrib><creatorcontrib>Salehi-Sadaghiani, Mohammad</creatorcontrib><creatorcontrib>Wang, Hongxing</creatorcontrib><creatorcontrib>Abbasi, Ata</creatorcontrib><creatorcontrib>Dehpour, Ahmad Reza</creatorcontrib><creatorcontrib>Ghia, Jean-Eric</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Progress in neuro-psychopharmacology &amp; biological psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Heydarpour, Pouria</au><au>Rahimian, Reza</au><au>Fakhfouri, Gohar</au><au>Khoshkish, Shayan</au><au>Fakhraei, Nahid</au><au>Salehi-Sadaghiani, Mohammad</au><au>Wang, Hongxing</au><au>Abbasi, Ata</au><au>Dehpour, Ahmad Reza</au><au>Ghia, Jean-Eric</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Behavioral despair associated with a mouse model of Crohn's disease: Role of nitric oxide pathway</atitle><jtitle>Progress in neuro-psychopharmacology &amp; biological psychiatry</jtitle><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><date>2016-01-04</date><risdate>2016</risdate><volume>64</volume><spage>131</spage><epage>141</epage><pages>131-141</pages><issn>0278-5846</issn><eissn>1878-4216</eissn><abstract>Crohn's disease (CD) is associated with increased psychiatric co-morbidities. Nitric oxide (NO) is implicated in inflammation and tissue injury in CD, and it may also play a central role in pathogenesis of the accompanying behavioral despair. This study investigated the role of the NO pathway in behavioral despair associated with a mouse model of CD. Colitis was induced by intrarectal (i.r.) injection of 2,4,6-trinitrobenzenesulfonic acid (10mg TNBS in 50% ethanol). Forced swimming test (FST), pharmacological studies and tissues collection were performed 72h following TNBS administration. To address a possible inflammatory origin for the behavioral despair following colitis induction, tumor necrosis factor-alpha (TNF-α) level was measured in both the hippocampal and colonic tissue samples. In parallel, hippocampal inducible nitric oxide synthase (iNOS) and nitrite level were evaluated. Pharmacological studies targeting the NO pathway were performed 30–60min before behavioral test. Colitis was confirmed by increased colonic TNF-α level and microscopic score. Colitic mice demonstrated a significantly higher immobility time in the FST associated to a significant increase of hippocampal TNF-α, iNOS expression and nitrite content. Acute NOS inhibition using either Nω-nitro-l-arginine methyl ester (a non-specific NOS inhibitor) or aminoguanidine hydrochloride (a specific iNOS inhibitor) decreased the immobility time in colitic groups. Moreover, acute treatment with both NOS inhibitors decreased the TNF-α level and nitrite content in the hippocampal samples. This study suggests that the NO pathway may be involved in the behavioral effects in the mouse TNBS model of CD. These findings endow new insights into the gut-brain communication during the development of colonic inflammation, which may ultimately lead to improved therapeutic strategies to combat behavior changes associated with gastrointestinal disorders. [Display omitted] •Colitis in mice is accompanied by an increase in the severity of behavioral despair.•Hippocampal iNOS, TNF-alpha and nitrite level are up-regulated.•NOS &amp; iNOS inhibitors attenuated the behavioral despair and central markers studied.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>26268932</pmid><doi>10.1016/j.pnpbp.2015.08.004</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-3018-9719</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0278-5846
ispartof Progress in neuro-psychopharmacology & biological psychiatry, 2016-01, Vol.64, p.131-141
issn 0278-5846
1878-4216
language eng
recordid cdi_proquest_miscellaneous_1710653006
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Antidepressive Agents - pharmacology
Behavioral despair
Colitis - pathology
Colitis - physiopathology
Colitis - psychology
Colon - drug effects
Colon - metabolism
Colon - pathology
Crohn Disease - drug therapy
Crohn Disease - pathology
Crohn Disease - physiopathology
Crohn Disease - psychology
Depression - drug therapy
Depression - pathology
Depression - physiopathology
Disease Models, Animal
Enzyme Inhibitors - pharmacology
Guanidines - pharmacology
Hippocampus - drug effects
Hippocampus - metabolism
Hippocampus - pathology
Inflammatory bowel disease
Male
Mice
Motor Activity - drug effects
Motor Activity - physiology
NG-Nitroarginine Methyl Ester - pharmacology
Nitric oxide
Nitric Oxide - metabolism
Nitric Oxide Synthase Type II - antagonists & inhibitors
Nitric Oxide Synthase Type II - metabolism
Nitrites - metabolism
Signal Transduction - drug effects
TNF-α
Trinitrobenzenesulfonic Acid
Tumor Necrosis Factor-alpha - metabolism
title Behavioral despair associated with a mouse model of Crohn's disease: Role of nitric oxide pathway
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T23%3A36%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Behavioral%20despair%20associated%20with%20a%20mouse%20model%20of%20Crohn's%20disease:%20Role%20of%20nitric%20oxide%20pathway&rft.jtitle=Progress%20in%20neuro-psychopharmacology%20&%20biological%20psychiatry&rft.au=Heydarpour,%20Pouria&rft.date=2016-01-04&rft.volume=64&rft.spage=131&rft.epage=141&rft.pages=131-141&rft.issn=0278-5846&rft.eissn=1878-4216&rft_id=info:doi/10.1016/j.pnpbp.2015.08.004&rft_dat=%3Cproquest_cross%3E1710653006%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1710653006&rft_id=info:pmid/26268932&rft_els_id=S0278584615300245&rfr_iscdi=true